Roflumilast demonstrated effectiveness and safety in treating psoriasis, with added benefits for patients with comorbidities.

A consistent safety profile and sustained efficacy were observed in patients with moderate to severe plaque psoriasis.

Individuals on immunosuppressants should discontinue them prior to patch testing, if at all possible, to avoid tarnishing the test results, according to updated guidelines from the North American ...

Alumis Inc. will merge with a Southern California drug developer in a deal that extends the combined companies' cash into ...

Age at initiation of treatment and the type of biologic therapy prescribed effect the rate of drug survival among patients with psoriasis.

Increland has identified proteolysis targeting chimera (PROTAC) compounds comprising an E3 ubiquitin ligase binding moiety covalently linked to an interleukin-1 receptor-associated kinase 4 (IRAK-4) ...

In a new study, researchers have determined that a protein called NF-kB c-Rel can intensify the symptoms of psoriasis when activated by signals from the body's immune system. Understanding how 'c-Rel' ...

For some people, psoriasis can be a painful source of insecurity, and covering it up might be a way to feel more confident. But not everyone with psoriasis feels this way. Some people choose to ...

While you're getting treated for psoriasis, make sure you find a way to manage the stress and emotions that may tag along. Reach out to family, friends, and support groups to get the backing you need.

White matter and other changes around the toenails and fingernails can occur with psoriasis or nail fungus. However, fungal infections are contagious, and psoriasis is not. The causes and ...

It can be difficult to tell the difference between seborrheic dermatitis vs. psoriasis when symptoms appear only on the scalp. Both conditions can cause scaly, red patches, but the specific appearance ...